Tag
nirsevimab
-
Beyfortus Vaccin: The Game-Changer in RSV Immunization Explained
The first RSV vaccine approved for universal infant use arrived in 2023, not as a traditional shot but as a single-dose monoclonal antibody. Beyfortus—marketed...
-
Beyfortus: The Game-Changing RSV Antibody Treatment Redefining Pediatric Care
Before Beyfortus , the only approved RSV prevention for high-risk infants was Synagis (palivizumab), an intravenous therapy requiring monthly injections. The...